The DOI matches its Crossref record.
Expression and localization of PCSK9 in rat hepatic cells
Abstract
Proprotein convertase subtilisin/kexin type 9 (PCSK9), recently cloned in several laboratories, including ours, causes a third form of autosomal dominant hypercholesterolemia. Its mechanism of action remains unclear. We studied the expression and subcellular localization of PCSK9 in fetal and adult rat tissues associated with cholesterol homeostasis using quantitative reverse transcriptase - PCR, Western blot analysis, subcellular fractionation, and confocal immuno fluorescent microscopy. PCSK9 mRNA is most abundant in yolk sac and fetal liver, but the highest expression of the protein was found in differentiated hepa toma FAO-1 cell line, which also shows the highest expression of LDLR. In FAO-1 cells PCSK9 expression is down regulated by cholesterol and 25-hydroxycholesterol and upregulated in the absence of sterols following the same pattern of expression as HMG-CoA reductase, synthase, and LDLR. Subcellular fractionation, combined with Western blotting, showed that PCSK9 is localized in the ER and intermediate vesicular compartment of the cell but not in Golgi cisternae. The mature enzyme is secreted from the liver and hepatoma cells. Double labeling with antibodies to PCSK9 and LDLR or clathrin revealed some colocalization of PCSK9 with clathrin-coated vesicles and LDLR. In conclusion, our results show that PCSK9 is processed in the ER, and the mature convertase is secreted in the plasma.Key words: PCSK9 expression, PCSK9 localization, hepatic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PCSK9 is synthesized as an approximately 75 kDa proprotein (proPCSK9, P-form), and its N-terminal prodomain is removed by autocatalysis generating an approximately 65 kDa C-form that is secreted.
“PCSK9 is synthesized as an approximately 75 kDa proprotein (proPCSK9, P-form); the N-terminal prodomain is then removed by autocatalysis (Seidah et al, 2003;Benjannet et al, 2004) generating an approximately 65 kDa form (C-form) that is secreted into the extracellular milieu (Grozdanov et al, 2006).”
From PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1 (2008) · cites this paper as Grozdanov et al, 2006
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- Abifadel M., 2003, Nat. Genet., 34, 154, 10.1038/ng1161 · DOI · Paper page
- Aridor M., 2000, J. Biol. Chem., 275, 35673, 10.1074/jbc.C000449200 · DOI
- Benjannet S., 2004, J. Biol. Chem., 279, 48865, 10.1074/jbc.M409699200 · DOI · Paper page
- Bostrom K., 1986, J. Biol. Chem., 261, 13800, 10.1016/S0021-9258(18)67090-5 · DOI
- Dabeva M.D., 2000, Am. J. Pathol., 156, 2017, 10.1016/S0002-9440(10)65074-2 · DOI
- Deschatrette J., 1974, Biochimie, 56, 1603, 10.1016/S0300-9084(75)80286-0 · DOI
- Donaldson J.G., 1992, Nature (London), 360, 350, 10.1038/360350a0 · DOI
- Dubuc G., 2004, Arterioscler. Thromb. Vasc. Biol., 24, 1454, 10.1161/01.ATV.0000134621.14315.43 · DOI · Paper page
- Farese R.V., Jr., 1996, J. Lipid Res., 37, 347, 10.1016/S0022-2275(20)37621-5 · DOI
- Gillian-Daniel D.L., 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 4337, 10.1073/pnas.072557199 · DOI · Paper page
- Horton J.D., 2003, Proc. Natl. Acad. Sci. U.S.A., 100, 12027, 10.1073/pnas.1534923100 · DOI · Paper page
- Jackson C.L., 2000, Trends Cell Biol., 10, 60, 10.1016/S0962-8924(99)01699-2 · DOI
- Kreis T.E., 1995, Rev. Cell Dev. Biol., 11, 677, 10.1146/annurev.cb.11.110195.003333 · DOI
- Larsson S.L., 2004, J. Biol. Chem., 279, 831, 10.1074/jbc.M303057200 · DOI
- Lee T.H., 2000, Mol. Biol. Cell, 11, 2577, 10.1091/mbc.11.8.2577 · DOI
- Leren T.P., 2004, Clin. Genet., 65, 419, 10.1111/j.0009-9163.2004.0238.x · DOI
- Maxwell K.N., 2004, Proc. Natl. Acad. Sci. U.S.A., 101, 7100, 10.1073/pnas.0402133101 · DOI · Paper page
- Maxwell K.N., 2003, J. Lipid Res., 44, 2109, 10.1194/jlr.M300203-JLR200 · DOI · Paper page
- Maxwell K.N, 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 2069, 10.1073/pnas.0409736102 · DOI · Paper page
- Naureckiene S., 2003, Arch. Biochem. Biophys., 420, 55, 10.1016/j.abb.2003.09.011 · DOI
- Oertel M., 2003, Hepatology, 37, 994, 10.1053/jhep.2003.50183 · DOI
- Ouguerram K., 2004, Arterioscler. Thromb. Vasc. Biol., 24, 1448, 10.1161/01.ATV.0000133684.77013.88 · DOI
- Park S.W., 2004, J. Biol. Chem., 279, 50630, 10.1074/jbc.M410077200 · DOI · Paper page
- Petkov P.M., 2000, Genomics, 68, 197, 10.1006/geno.2000.6294 · DOI
- Rozen, S., and Skaletsky, H.J. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics methods and protocols: methods in molecular biology. Edited by S. Krawetz and S. Misener S. Humana Press, Totowa, N.J. pp. 365-386. · DOI
- Scales S.J., 2000, Int. Rev. Cytol., 195, 67, 10.1016/S0074-7696(08)62704-7 · DOI
- Seidah N.G., 2003, Proc. Nat. Acad. Sci. U.S.A., 100, 928, 10.1073/pnas.0335507100 · DOI · Paper page
- Shioji K., 2004, J. Hum. Genet., 49, 109, 10.1007/s10038-003-0114-3 · DOI
- Strausberg R.L., 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 16899, 10.1073/pnas.242603899 · DOI
- Terasawa Y., 1999, J. Lipid Res., 40, 1967, 10.1016/S0022-2275(20)32420-2 · DOI
- Timms K.M., 2004, Hum. Genet., 114, 349, 10.1007/s00439-003-1071-9 · DOI
- Twisk J., 2000, J. Clin. Investig., 105, 521, 10.1172/JCI8623 · DOI
Cited by
Sorted by citations
Jonas, M. C., Costantini, C., & Puglielli, L. (2008) · The EMBO Reports · doi:10.1038/embor.2008.132 · Cited by 119
Metadata
- Authors
- Grozdanov, P. N., Petkov, P. M., Karagyozov, L. K., & Dabeva, M. D.
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2006-02-01
- Volume
- 84
- Issue
- 1
- Pages
- 80-92
- ISSN
- 0829-8211
- 1208-6002
- Cited by
- 25
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review